BIOMAT Database Logo BIOMAT Database Logo

Dihydro-[1H]-quinolin-2-ones as retinoid X receptor (RXR) agonists for potential treatment of dyslipidemia. 2007

Bharat Lagu, and Rimma Lebedev, and Barbara Pio, and Maria Yang, and Patricia D Pelton
Johnson and Johnson Pharmaceutical Research and Development, Cranbury, NJ 08512, USA. bharat.lagu@novartis.com

A number of RXR modulators with novel structural features were synthesized and screened in the functional assays. The synthesis and the structure-activity relationship within the series of compounds will be presented. Some in vivo data generated in the models for dyslipidemia and diabetes will also be presented.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015363 Quinolones A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID. Ketoquinoline,Ketoquinolines,Oxoquinoline,Oxoquinolines,Quinolinone,Quinolinones,Quinolone
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D047488 Retinoid X Receptors A subtype of RETINOIC ACID RECEPTORS that are specific for 9-cis-retinoic acid which function as nuclear TRANSCRIPTION FACTORS that regulate multiple signaling pathways. Retinoid X Receptor,9-cis-Retinoic Acid Receptor,RXR Protein,Receptor, Retinoid X,XR78E-F protein,Protein, RXR,Receptor, 9-cis-Retinoic Acid,Receptors, Retinoid X,XR78E F protein,protein, XR78E-F
D050171 Dyslipidemias Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL. Dyslipoproteinemias,Dyslipidemia,Dyslipoproteinemia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Bharat Lagu, and Rimma Lebedev, and Barbara Pio, and Maria Yang, and Patricia D Pelton
Diarylamines incorporating hexahydrophenalene or octahydrobenzoheptalene as retinoid X receptor (RXR)-specific agonists.
January 2014, Chemical & pharmaceutical bulletin,
Bharat Lagu, and Rimma Lebedev, and Barbara Pio, and Maria Yang, and Patricia D Pelton
Alternative retinoid X receptor (RXR) ligands.
July 2019, Molecular and cellular endocrinology,
Bharat Lagu, and Rimma Lebedev, and Barbara Pio, and Maria Yang, and Patricia D Pelton
Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulators.
October 2007, Journal of medicinal chemistry,
Bharat Lagu, and Rimma Lebedev, and Barbara Pio, and Maria Yang, and Patricia D Pelton
Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis.
July 2003, Arteriosclerosis, thrombosis, and vascular biology,
Bharat Lagu, and Rimma Lebedev, and Barbara Pio, and Maria Yang, and Patricia D Pelton
Functional evidence for retinoid X receptor (RXR) as a nonsilent partner in the thyroid hormone receptor/RXR heterodimer.
August 2002, Molecular and cellular biology,
Bharat Lagu, and Rimma Lebedev, and Barbara Pio, and Maria Yang, and Patricia D Pelton
Rapid and efficient synthesis of 1H-indol-2-yl-1H-quinolin-2-ones.
October 2003, Organic letters,
Bharat Lagu, and Rimma Lebedev, and Barbara Pio, and Maria Yang, and Patricia D Pelton
2-(2-Chloro-6,7-dimethyl-quinolin-3-yl)-2,3-dihydro-quinolin-4(1H)-one.
August 2011, Acta crystallographica. Section E, Structure reports online,
Bharat Lagu, and Rimma Lebedev, and Barbara Pio, and Maria Yang, and Patricia D Pelton
Developmental expression of murine retinoid X receptor (RXR) genes.
February 1994, Mechanisms of development,
Bharat Lagu, and Rimma Lebedev, and Barbara Pio, and Maria Yang, and Patricia D Pelton
Identification of Novel Quinolin-2(1H)-ones as Phosphodiesterase 1 Inhibitors for the Treatment of Inflammatory Bowel Disease.
September 2023, Journal of medicinal chemistry,
Bharat Lagu, and Rimma Lebedev, and Barbara Pio, and Maria Yang, and Patricia D Pelton
Synthesis of symmetrically substituted 3,3-dibenzyl-4-hydroxy-3,4-dihydro-1H-quinolin-2-ones, as novel quinoline derivatives with antibacterial activity.
June 2014, European journal of medicinal chemistry,
Copied contents to your clipboard!